Collimator

Details Collimator Collimator

2007-07-31

2007-07-31

Porta, David (Department: 2884)

Radiant energy

Invisible radiant energy responsive electric signalling

With or including a luminophor

C250S505100, C378S149000

Reexamination Certificate

active

11066085

ABSTRACT:
A collimator suitable for the collimation of high energy gamma photons.

REFERENCES:
patent: 4054800 (1977-10-01), Leask
patent: 4118632 (1978-10-01), Luig
patent: 4288697 (1981-09-01), Albert
patent: 4419585 (1983-12-01), Strauss et al.
patent: 4528453 (1985-07-01), Heller
patent: 4792686 (1988-12-01), Karcher et al.
patent: 5077479 (1991-12-01), de la Barre et al.
patent: 5293417 (1994-03-01), Wei et al.
patent: 5436958 (1995-07-01), Taylor
patent: 5448073 (1995-09-01), Jeanguillaume
patent: 5751000 (1998-05-01), McCroskey et al.
patent: 5929447 (1999-07-01), Crandall et al.
patent: 6271524 (2001-08-01), Wainer et al.
patent: 6353227 (2002-03-01), Boxen
patent: 6518579 (2003-02-01), Xu et al.
Votion, D.M., “Scintigraphy”,Equine Respiratory Diseases, [online] Dec. 4, 2001, Publisher: International Veterinary Service [retrieved May 10, 2005] (www.ivis.org), Ithaca,NY, USA.
Corrado, M., “Preparazione Di Forme Farmaceutiche Orali Per Studi Di Farmacoscintigrafia”, presentation, Switzerland, [retrieved May 10, 2005] <URL:www.pharm.unipmm.it/link—statici/giornate—di—studio—e—convegni/26—11—03/Corrado.pdf.>.
Merck Index, “Radioactive Isotopes Used in Medical Diagnosis and Therapy”, [retrieved May 10, 2005], URL:themerckin1dex.cambridgesoft.com/.../AdditonalTables/pdfs/RadioactiveIsotopeusedinMedicalDiagnosis.pdf.
Theodorakis, M.C. et al., “External Scintigraphy in Monitoring the Behavior of Pharmaceutical Formulations In Vivo I: Technique for Acquiring High-Resolution Images of Tablets”,J. of Pharmaceutical Science, 1983, vol. 72, No. 2, pp. 130-135.
Parr, A.F. et al., “Correlation of Ibuprofen Bioavailability with Gastrointestinal Transit by Scintigraphic Monitoring of171Er-Labeled Sustained-Rlease Tablets”,Pharmaceutical Research, 1987, vol. 4, No. 6, pp. 486-489.
Digenis, G.A. et al., “Gastrointestinal Behavior of Orally Administered Radiolabeled Erythromycin Pellets in Man as Determined by Gamma Scintigraphy”,J. Clin. Pharmacol, 1990, vol. 30, pp. 621-631.
Digenis, G.A. et al., “Dual-Isotope Imaging of Neutron-Activated Erbium-171 and Samarium-153 and the in vivo Evaluation of a Dual-Labeled Bilayer Tablet by Gamma Scintigraphy”,Pharmaceutical Research, 1991, vol. 8, No. 10, pp. 1335-1340.
Wilding, I.R. et al, “In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy”,Pharmaceutical Research, 1992, vol. 9, No. 11, pp. 1436-1441.
Adkin, D.A. et al., “The effects of pharmaceutical excipients on small intestinal transit”,Br. J. Clin. Pharmacol., 1995, vol. 39, No. 4, pp. 381-387.
Burton, S. et al., “Intragastric Distribution of Ion-exchange Resins: a Drug Delivery System for the Topical Treatment of the Gastric Mucosa”,J. Pharm. Pharmacol., 1995, vol. 47, pp. 901-906.
Adkin, D.A. et al., “The Use of Scintigraphy to Provide ‘Proof of Concept’ for the Novel Polysaccharide Preparations Designed for colonic Drug Delivery”,Pharmaceutical Research, 1997, vol. 14, No. 1, pp. 103-107.
Wilding, I.R. et al., “Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet”,Aliment Pharmacol Ther., 2000, vol. 14, pp. 163-169.
Perkins, A.C. et al., “Oesophgeal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects”,Aliment Pharmacol Ther., 2001, vol. 15, pp. 115-121.
Perkins, A.C. et al., “Impaired oesophageal transit of capsule versus tablet formulations in the elderly”,Gut, 1994, vol. 35, No. 10, pp. 1363-1367.
Billa, N. et al., “Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices”,International J. Pharmaceutics, 2000, vol. 201, pp. 109-120.
Perkins, A.C. et al., “The use of scintigraphy to demonstrate the rapid esophaegeal trnsit of the oval film-coated placebo risdronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water”,International J. of Pharmaceutics, 2001, vol. 222, pp. 295-303.

Affiliated with

Also associated with

Rating

Collimator does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Collimator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Collimator will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3765184